In This Section

Home / Learn / Cancer Types / Gynecologic Cancer

Gynecologic Cancer

ACCC and its partner programs are working together on numerous projects aimed at improving the quality of patient care and survival rates for all who are diagnosed with gynecologic cancer.

If detected early, gynecologic cancer—including cervical, ovarian, uterine, vaginal, and vulvar— can be easily treated. However, in its early stages, patients may experience a wide range of symptoms which can be easily mistaken for other conditions. Unfortunately, currently, the only type of gynecologic cancer with a screening test is cervical cancer.

For those with a family history of gynecologic cancers, genetic testing may be beneficial, depending on the type of cancer. Patients who have tested positive for human papillomavirus (HPV) are also at higher risk of developing gynecologic cancer.

Aims of the initiative include identification and assessment of necessary components for the provision of high-quality multidisciplinary care delivery for patients with gynecologic cancers.

When identified and treated at an early stage, the five-year survival rate for patients with ovarian cancer is approximately 49 percent. Unfortunately, most ovarian cancers are not identified until an advanced stage.

Gynecologic Cancer Resources

On-Demand Webinars

Provision of High-Quality Ovarian Cancer Care Delivery Through Multidisciplinary Coordination and Communication

Explore the impact of ACCC’s quality improvement initiative on several ovarian cancer care programs and learn about the ovarian quality of care self-assessment tool.
From Process to Quality Improvement: Lessons Learned on Addressing Quality Care in Ovarian Cancer

Review key issues and takeaways during early phases of this ovarian cancer care quality improvement initiative.
Perfecting Placement of PARPS: Preventing Progression of Ovarian Cancer

From Oncology Issues

Genetic Counseling Referrals Among Cancer Registry Patients Who Meet NCCN Guidelines: An Ohio Study
By Lindsey Byrne, et al.

A multicentered study based in Ohio measured genetic counseling referrals for patients with cancer.
A Multidisciplinary Consortium to Advance Counseling in Oncology

The Iowa Oncology Society launched an educational project designed to spark conversations, and raise awareness about the importance of genetic testing, counseling, and screening.
Improving the Quality of Care for Persons With Advanced Epithelial Ovarian Cancer
Premal H. Thaker, MD, MS, et al.

Cancer programs of all types across the U.S. face similar challenges in providing quality care for women with ovarian cancer. Multiple stakeholders can contribute to QI solutions with a team approach and clear communication around quality gaps.